Limitations and niches of the active targeting approach for nanoparticle drug delivery
Open accessThe DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
The active targeting approach has been widely employed to improve nanoparticle drug delivery. Contrary to popular conceptions, attachment of a targeting ligand to a nanopaticle does not alter its biodistribution, but only increases its internalization by target cells. Despite its potential, this strategy has drawbacks that can negate efficacy against tumors. Specifically, compared to non-targeted nanoparticles, a number of active targeting nanoparticles have decreased blood circulation time due to non-specific binding or immunogenicity, reduced tumor penetration, and high susceptibility to lysosomal degradation after internalization. In order to maximize the advantages and overcome the disadvantages, the active targeting approach is best suited for delivering membrane impermeable drugs to targets directly exposed to i.v. injected nanoparticles, such as those in circulation or in the luminal site of tumor vasculatures.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lee, H., Fonge, H., Hoang, B., Reilly, R. M., & Allen, C. (2010) · Molecular Pharmaceutics · doi:10.1021/mp100038h · Cited by 349
Cited by
Advances in drug delivery systems, challenges and future directions
Ezike, T. C., Okpala, U. S., Onoja, U. L., Nwike, C. P., Ezeako, E. C., Okpara, O. J., Okoroafor, C. C., Eze, S. C., Kalu, O. L., Odoh, E. C., et al. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e17488 · Cited by 1,040
Zhang, Z., Wang, J., Nie, X., Wen, T., Ji, Y., Wu, X., Zhao, Y., & Chen, C. (2014) · Journal of the American Chemical Society · doi:10.1021/ja412735p · Cited by 635
Antibody fragments as nanoparticle targeting ligands: a step in the right direction
Richards, D. A., Maruani, A., & Chudasama, V. (2017) · Chemical Science · doi:10.1039/c6sc02403c · Cited by 294
Nano-engineered mesenchymal stem cells as targeted therapeutic carriers
Sadhukha, T., O'Brien, T. D., & Prabha, S. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.10.015 · Cited by 115
Targeting cancer cells via tumor-homing peptide CREKA functional PEG nanoparticles
Okur, A. C., Erkoc, P., & Kizilel, S. (2016) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2016.08.005 · Cited by 60
Metadata
- Authors
- Chen, W. C., Zhang, A. X., & Li, S.-D.
- Venue
- ejnm
- Publisher
- Walter de Gruyter GmbH
- Published
- 2012-11-30
- Volume
- 4
- Issue
- 2-4
- Pages
- 89-93
- ISSN
- 1662-596X (ISSN-L)
- 1662-5986
- OpenAlex
- W2005569083
- Cited by
- 66
- References
- 1
- FWCI
- 1.08
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Limitations and niches of the active targeting approach for nanoparticle drug delivery. https://app.cochat.ai/papers/10.1515/ejnm-2012-0010
- The paper
- Chen, W. C., Zhang, A. X., & Li, S.-D. (2012). Limitations and niches of the active targeting approach for nanoparticle drug delivery. ejnm. https://doi.org/10.1515/ejnm-2012-0010
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.